The synthetic streptococcus pneumoniae oligosaccharide conjugate protected mice from severe pneumonia

K. Reppe, C. Anish, R. Bell, S. G. Parameswarappa, S. Govindan, C. L. Pereira, K. Dietert, L. E. Sander, A. D. Gruber, N. Suttorp, P. H. Seeberger, M. Witzenrath (Berlin, Potsdam, Germany)

Source: International Congress 2014 – Lung cell biology in injury and repair
Session: Lung cell biology in injury and repair
Session type: Thematic Poster Session
Number: 889
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Reppe, C. Anish, R. Bell, S. G. Parameswarappa, S. Govindan, C. L. Pereira, K. Dietert, L. E. Sander, A. D. Gruber, N. Suttorp, P. H. Seeberger, M. Witzenrath (Berlin, Potsdam, Germany). The synthetic streptococcus pneumoniae oligosaccharide conjugate protected mice from severe pneumonia. Eur Respir J 2014; 44: Suppl. 58, 889

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Development of an antibody therapy for the treatment of pneumonia
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Aerobic exercise inhibits pseudomonas aeruginosa-induced acute lung injury in elderly mice
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014


Evolutionary trend of invasive pneumococcal disease according to serotypes
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014

Ventilator-Induced Lung Injury Increases Systemic Inflammation in Murine Pseudomonas Aeruginosa Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

Emerging macrolide-resistant mycoplasma pneumoniae in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Chronic pulmonary infection with streptococcus pneumoniae during ovalbumin allergic inflammation
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013